Go to content
UR Home

IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)

URN to cite this document:
urn:nbn:de:bvb:355-epub-355444
DOI to cite this document:
10.5283/epub.35544
Wege, Anja K. ; Weber, Florian ; Kroemer, Alexander ; Ortmann, Olaf ; Nimmerjahn, Falk ; Brockhoff, Gero
Date of publication of this fulltext: 07 Apr 2017 08:57



Abstract

Cancer immunotherapy has been shown to enhance established treatment regimens. We evaluated the potential reinforcing effect of IL-15 in trastuzumab treated humanized tumor mice (HTM) which were generated by concurrent transplantation of neonatal NOD-scid IL2R.null mice with human hematopoietic stem cells (HSC) and HER2 positive breast cancer cells (metastasizing SK-BR-3, solid tumor forming ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons